These speculations are also supported by studies that found an increased risk of CRC in patients with Type 2 diabetes [35-37], as hyperinsulinemia is also related to increased levels of insulin-like growth factor 1, which is known to have cancer promoting effects [38-40]. This evidence concerns the gene IGF1 and hyperinsulinism.